GILEAD SCIENCES INC - United States 

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:> 1000
Total Number of Projects:> 1000
2010
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2010-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 4
As coordinator: 0
As participant: 4
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2020 0 9.983.029 0 1
2017 0 15.797.881 0 1
2016 0 1.674.240 0 1
2010 0 11.999.998 0 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
KAROLINSKA INSTITUTE3
ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON2
FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR2
KING'S COLLEGE LONDON2
THE UNIVERSITY OF LIVERPOOL2
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM1
ACADEMISCH ZIEKENHUIS GRONINGEN1
ALLERGAN LIMITED1
ANTAROS MEDICAL AB1
ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOCIENCIAS1
ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOMATERIALES1
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS1
ASTRAZENECA AB1
AZIENDA OSPEDALIEROUNIVERSITARIA DI PARMA1
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG1
BRISTOLMYERS SQUIBB COMPANY CORP1
CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS1
CHECKPOINTS1
CHR HANSEN1
CHU HOPITAUX DE BORDEAUX1
COMMISSARIAT A L'ENERGIE ATOMIQUE1
COPAN1
COUNCIL FOR SCIENTIFIC AND INDUSTRIAL RESEARCH1
ECHOSENS1
EDINBURGH MOLECULAR IMAGING1
ELI LILLY AND COMPANY LIMITED1
ELLEGAARD GOTTINGEN MINIPIGS AS1
EUROPEAN AIDS TREATMENT GROUP EV1
EUROPEAN ASSOCIATION FOR THE STUDYOF THE LIVER1
EUROPEAN LIVER PATIENTS ASSOCIATION1
EXALENZ BIOSCIENCE1
FACULDADE DE FARMACIA DA UNIVERSIDADE DE LISBOA1
FACULDADE DE MEDICINA DA UNIVERSIDADE DE LISBOA1
FONDATION MINTAKA POUR LA RECHERCHE MEDICALE1
FONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO1
FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON INSTITUT DE RECERCA1
GENFIT1
HISTOINDEX PTE1
HOSPICES CIVILS DE LYON1
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE1
INSERM TRANSFERT1
INST CARDIOMETABOLISME NUTRITION ICAN1
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE1
INSTITUT PASTEUR1
INSTITUTE OF PHOTONIC TECHNOLOGY LEIBNIZ1
INSTITUTO DE SALUD CARLOS III1
INTEGRATED DISEASE MANAGEMENT CORPORATION BV1
INTERCEPT PHARMA EUROPE1
INTERNATIONAL PARTNERSHIP FOR MICROBICIDES INC1
IXSCIENT LIMITED1
JANSSEN INFECTIOUS DISEASES DIAGNOSTICS BVBA JANSSEN INFECTIOUS DISEASES BVBA JANSSEN DIAGNOSTICS BVBA1
JULIUSMAXIMILIANS UNIVERSITAET WUERZBURG1
KATHOLIEKE UNIVERSITEIT LEUVEN1
LABHELP INTERNATIONAL BV1
LINKOPINGS UNIVERSITET1
LUXEMBOURG INSTITUTE OF HEALTH1
MAD MULTIMEDIA1
MEDIZINISCHE UNIVERSITAET WIEN1
MICROBIOTEC1
MIDDLESEX UNIVERSITY1
MINERVA CONSULTING & COMMUNICATION1
MSD BV1
NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS1
NATIONAL ENTEROVIRUS REFERENCE CENTER1
NORDIC BIOSCIENCE1
NORDIC BIOSCIENCE COMPOUND DEVELOPMENT1
NOVARTIS PHARMA1
NOVO NORDISK1
NUTRICIA RESEARCH BV1
ONE WAY LIVER SL1
OREBRO UNIVERSITY1
PARTICLE SCIENCES INC1
PERSPECTUM DIAGNOSTICS1
PFIZER LIMITED1
POLYMUN SCIENTIFIC IMMUNBIOLOGISCHE FORSCHUNG1
PRINS LEOPOLD INSTITUUT VOOR TROPISCHE GENEESKUNDE1
QUEEN MARGARET UNIVERSITY EDINBURGH1
RESEARCH TRIANGLE INSTITUTE1
RESOUNDANT INC1
SANOFIAVENTIS DEUTSCHLAND1
SERVICIO ANDALUZ DE SALUD1
SOMALOGIC INC1
SPOLUKA CHEMICAL COMPANY1
ST GEORGE'S HOSPITAL MEDICAL SCHOOL1
STICHTING AMSTERDAM INSTITUTE FOR GLOBAL HEALTH AND DEVELOPMENT1
STICHTING WETSUS EUROPEAN CENTRE OF EXCELLENCE FOR SUSTAINABLE WATER TECHNOLOGY1
TAKEDA DEVELOPMENT CENTRE EUROPE1
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD1
THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE1
THE QUEEN'S UNIVERSITY OF BELFAST1
THE UNIVERSITY OF ADELAIDE1
THE UNIVERSITY OF NOTTINGHAM1
THERMOFISHER SCIENTIFIC1
UCBPHARMA1
UNIVERSITA CATTOLICA DEL SACRO CUORE1
UNIVERSITA DEGLI STUDI DI MILANO1
UNIVERSITA DEGLI STUDI DI PALERMO1
UNIVERSITA DEGLI STUDI DI PARMA1
UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA1
UNIVERSITA DEGLI STUDI DI SIENA1

Constancy:

Total number of partners: 129
Partner loyalty:
Frequent Partner: (> 2 projects): 3
Rare Partner: 126
Frequent / Rare Partner Ratio: 0.02

Project overview:

Start dateProjectacronymrolefundingpartners
2020-01-01Immune profiling to guide host-directed interventions to cure HBV infections IP-cure-Bparticipant9.983.02916
2017-11-01Liver Investigation: Testing Marker Utility in Steatohepatitis LITMUSparticipant15.797.88156
2016-09-01Protecting patients with enhanced susceptibility to infections PRONKJEWAILparticipant1.674.24027
2010-01-01Combined Highly Active Anti-retroviral Microbicides CHAARMparticipant11.999.99834

Alias institution names:

  • GILEAD SCIENCES INC